New possibilities of movalis administration in rheumatic diseases

Abstract

Objective. To study efficacy and safety of "stepped" movalis therapy (parenteral administration of the drug during 3 days and subsequent oral therapy with 15 mg/day for 20 days). Material and methods. Clinical indices (pain at rest and al movement, functional disability and local inflammation degree) were assessed with 10-point scale in 30 pts with osteoarthritis and rheumatoid arthritis before treatment and at different stages of therapy. Assessment of systemic and local drug safety was performed. Results. Intramuscular movalis administration provided fast analgesic and anti-inflammatory response. Achieved significant improvement increased during the second stage of treatment with movalis (oral). Conclusion. The results of the study show high efficacy and safety of new movalis administration scheme.